| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4749039
Max Phase: Preclinical
Molecular Formula: C16H20F4N2O2
Molecular Weight: 348.34
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COC(=O)N(CC(C)(C)N)C1(c2ccc(F)c(C(F)(F)F)c2)CC1
Standard InChI: InChI=1S/C16H20F4N2O2/c1-14(2,21)9-22(13(23)24-3)15(6-7-15)10-4-5-12(17)11(8-10)16(18,19)20/h4-5,8H,6-7,9,21H2,1-3H3
Standard InChI Key: WIAUIJHTIFNYNU-UHFFFAOYSA-N
Associated Targets(Human)
Intermediate conductance calcium-activated potassium channel protein 4 87 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 348.34 | Molecular Weight (Monoisotopic): 348.1461 | AlogP: 3.64 | #Rotatable Bonds: 4 |
| Polar Surface Area: 55.56 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.62 | CX LogP: 3.07 | CX LogD: 0.91 |
| Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -0.80 |
References
| 1. Blass BE.. (2020) Novel Potassium Channel Inhibitors., 11 (12.0): [PMID:33335651] [10.1021/acsmedchemlett.0c00569] |
Source
Source(1):